Team:Heidelberg/Delftibactin/DelRest

From 2013.igem.org

(Difference between revisions)
Line 147: Line 147:
                                   <h1>Week 17</h1>
                                   <h1>Week 17</h1>
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">
-
Since we were able to rescue 3 plasmids, from colonies which were positive for screening, by the end of last week, this week further colony PCRs, test restriction digests and sequencings will be conducted to validate the final construct. Therefore we will initially focus on clone D8w, as preps of this clone are already available.
+
Since we were able to rescue 3 candidate plasmids, from colonies which were positive for screening, by the end of last week. This week further colony PCRs, test restriction digests and sequencings will be conducted to validate the final construct. Initially we are going to focus on the plasmid from clone D8w, as preps of this clone are already available.
-
Consequently screening primers will be used to check whether all fragments are present in the final vector as well as to sequence the relevant ligation sites for any mutations that might have occured during primer synthesis or assembly.
+
Consequently our screening primers will be used to check whether all fragments used in the Gibson Assembly are present in the final vector as well as to sequence the relevant ligation sites for any mutations that might have occured during primer synthesis or assembly.
Afterwards plasmids will be preped for further use and glycerol stocks of DH10B-pFSN will be made.
Afterwards plasmids will be preped for further use and glycerol stocks of DH10B-pFSN will be made.

Revision as of 20:20, 2 October 2013

Del Rest. Creating a 32 kbp plasmid.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Methods: